Publication | Closed Access

Nivolumab with or without ipilimumab in patients with recurrent or metastatic cervical cancer (CheckMate 358): a phase 1–2, open-label, multicohort trial

Checkmate 358Metastatic Cervical CancerCervical CancerMedicineClinical TrialsGynecologyImmune Checkpoint InhibitorCancer TreatmentOncologyMulticohort TrialGynecology Oncology